Pfizer revives weight-loss drug
Pfizer (PFE.N) declared its arrangement to begin clinical preliminaries in the not-so-distant future for a revised, once-everyday rendition of its weight reduction pill, danuglipron. This comes subsequent to stopping a two-times day-to-day form of the medication last year because of high dropout rates and critical incidental effects, like sickness and retching. The reconsidered rendition of … Read more